Enzo Biochem, Inc. (XNYS:ENZ). is a biotechnology company that focuses on developing and commercializing innovative diagnostic and therapeutic products for clinical and research use. The company was founded in 1976 and is headquartered in New York City.
Enzo Biochem’s products and services are primarily focused on the life sciences and medical research markets. The company’s main areas of expertise include molecular biology, immunology, and cellular biology, and it offers a wide range of research reagents, assays, and platforms to support these areas. The company also develops and markets a variety of diagnostic products, including assays for infectious diseases, genetic disorders, and cancer, as well as immunohistochemistry and in situ hybridization products for pathology laboratories.